Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccines & Related Biological Products

Executive Summary

A discussion of cell substrates used to produce vaccines has been added to the agenda of the FDA advisory committee's Nov. 19 meeting. The meeting will be open from 8 a.m. to 1:30 p.m., after which the committee will meet in closed session to discuss trade secret or confidential information. On Nov. 20, the committee is set to discuss the manufacture of influenza vaccines ("The Pink Sheet" Oct. 19, In Brief). The meeting is to be held at the Holiday Inn in Bethesda, Md
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS033092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel